The Latest Breaking News on Pharma

Take AstraZeneca’s warning seriously. The UK is missing out in life sciences

Big pharma has choices about where to make new investments and, increasingly it seems, it is not choosing Britain

The Guardian - UK · Feb 9, 2023

Centene Corp. settles for $215 million on California Medicaid overbilling accusations

More than 20 states are investigating or have investigated Centene’s Medicaid pharmacy billing. The company also has agreed to pay settlements to at least 16 other states, including Illinois and Indiana.

Chicago Sun-Times · Feb 9, 2023

Shield Therapeutics revenues boosted by US sales of iron deficiency pills

The pharmaceuticals firm recently joined forced with Pennsylvania-based Viatris to tackle the American market

Birmingham Post · Feb 9, 2023

Nodus Oncology secures £2.4 million investment

Edinburgh-based start-up will now be able to accelerate development of its life sciences technology

Insider UK · Feb 7, 2023

Workers resume strike action as union admit dispute could drag on

Unite chiefs say their members are determined to get 'what they are owed' in bonus payments row.

Daily Record · Feb 6, 2023

Want to Get Richer in 2023? Try This Medical Stock

Mckesson Corporation (MCK) delivered better-than-expected earnings for the last quarter and updated its outlook for fiscal 2023. Wall Street analysts expect the stock to rise more than 18% in the near term. Therefore, it could be wise to buy this medical stock now. Read more….

StockNews.com · Feb 6, 2023

Pharma giant tops new business gender equality index

‘Lead5050 Index provides a comprehensive snapshot of how well employers tackle the gender pay gap’

The Independent UK · Feb 6, 2023

ASX drug companies applaud TGA's psychedelic ruling

Shares in Little Green Pharma and Emyria are up by more than 40 per cent as both announce plans to take advantage of Australia's "world-leading" drug decision.

AAP · Feb 6, 2023

'Possibly contaminated' eye drops recalled after patient dies of bloodstream infection

A total of 55 patients reported adverse effects after using EzriCare and Delsam Pharma's Artificial Tears, including eye infections, permanent loss of vision, and a death with a bloodstream infection

Daily Mirror · Feb 4, 2023

‘Thanks Pfizer’: The weird world of shakes, health anxiety and illness online

Eloise Hendy asks psychologists and doctors if the viral wave of vaccine-induced symptoms is real or faked or something else entirely

The Independent UK · Feb 4, 2023